VGT-1849B

N/A

Report date: 2026/04/14 20:00:15

NME

Base Information

Drug NameVGT-1849B

Drug Alias NameVGT-1849B

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisenseSmall molecules > Nucleosides and nucleotide derivtives > Peptide nucleic acids

Mechanisms of ActionTyrosine-protein kinase JAK2 inhibitors

TargetsTyrosine-protein kinase JAK2

Therapy Area/IndicationsPolycythemia Vera

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesVanda Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesVanda Pharmaceuticals Inc

Inactive CompaniesN/A

Active IndicationsPolycythemia Vera

Inactive IndicationsN/A

Other Information

ATC CodeN/A